glp-1 management platforms startups 2.0: Where the Next Wave of Value Will Be Created digital health companies glp-1 management

Preclinical data indicate that Dihexa functions as a potent small-molecule agonist of the HGF/c-Met receptor system

Key Areas of Research Structural: collagen, matrix, tendon Vascular: angiogenesis, nitric oxide, signaling Epithelial: migration, vessel formation, matrix Systemic: signaling, viability, pathway dynamics References Sikiric P

doi:10.1213/ANE.0000000000001546 Donovan LM, Kapur VK

10.1016/j.jamda.2020.02.022 160

Across all GLP-1 medications, 12-month persistence (still taking the medication at one year) ranges from 38% to 56% depending on the study and population (Wilding et al., Diabetes Obes Metab 2023)